Abstract:Objective: High-sensitivity C-reactive protein (hs-CRP) may predict the development of type 2 diabetes mellitus (T2DM), metabolic syndrome (MS) and cardiovascular diseases (CVD) in adult, but few reports on relevant studies in children are available. The present study aimed to understand possible correlation between serum hs-CRP levels and some factors of obese children and adolescents with or without impaired glycometabolism. Methods: Seventy obese children and adolescents (age 8 - 17 years) and 30 non-obese healthy controls (group 1, 20 boys and 10 girls, mean age 12.6 years) were enrolled into this study. The obese individuals were subdivided into two groups according to the results of oral glucose tolerance test: the obese subjects without IGR (group 2, 54 cases, 43 boys and 11 girls, mean age 11.3 years) and the obese subjects with impaired glycometabolism (group 3, 16 cases, 8 boys and 8 girls, mean age 12.8 years). The levels of serum parameters including hs-CRP, glucose, lipid, insulin, C-peptide and whole blood HbA1c were determined. SPSS 10.0 was used for statistical analysis. Results: (1) There was significant increase of serum hs-CRP level in obese children and adolescents, the median was 2.44 (0.01 - 14.6) mg/L; the level of control group was 0.1 (0.01 - 2.1) mg/L. (2) Some of the following parameters, such as fasting plasma glucose (FPG), triglyceride (TG), fasting insulin (FINS), C-peptide (Cp) and insulin resistance index (IRI), were found increased in group 2 and 3 as compared to group 1. When FPG and TG were still in normal range in group 2, the levels of hs-CRP and IRI were significantly higher than those in group 1, the level of hs-CRP was 2.4 (0.01 - 9.0) mg/L. While FPG and TG were abnormal in group 3, the level of hs-CRP was 2.6 (0.1 - 14.6) mg/L, but the difference had no statistical significance. (3) Pearson correlation analysis showed that there was a moderate correlation between serum hs-CRP and BMI (r = 0.414, P = 0.000). There was a low correlation between hs-CRP and waist circumference, hip circumference and waist to hip ratio (WHR). The correlation of serum hs-CRP with blood pressure, TG, cholesterol, high density lipoprotein-cholesterol (HDL-C), HbA1c, FPG, FINS and Cp had no significant deviation. (4) Multiple linear regression analysis showed that body mass index (BMI) was the only indicator which had correlation with hs-CRP. Conclusion: (1) There may be a chronic low-grade inflammation and insulin resistance in obese children. (2) The level of hs-CRP might be independently correlated with BMI in children. (3) Hs-CRP and IRI elevated before FPG and TG did, which may suggest that the low-grade inflammation and insulin resistance may be a pathogenic base of DM rather than the outcome of it. (4) The elevation of hs-CRP may help predict impaired glucose and lipid metabolism.

Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity

Serum N-3 Polyunsaturated Fatty Acid and High-sensitivity C Reactive Protein in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently.

Association Between Serum Adiponectin and Insulin Sensitivity Index in IGT Subjects and Newly Diagnosed T2DM Patients

Low Serum Total Bilirubin Concentration Was Associated with Increased High Sensitive C Reactive Protein Level in Patients with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus Subjects

Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population.

Relationship Between Serum Adipsin and the First Phase of Glucose‐stimulated Insulin Secretion in Individuals with Different Glucose Tolerance

Study of Correlation Between Serum Adiponectin Level and Insulin Sensitivity in Patients with Insulin Resistance Syndrome

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Circulating CTRP9 Levels Are Increased in Patients with Newly Diagnosed Type 2 Diabetes and Correlated with Insulin Resistance

High Sensitive C-reactive Protein, Adiponectin, and Urine Albumin Excretion Rate in Chinese Coronary Artery Disease Patients with Different Glucose Tolerance Status

High Sensitivity C-reactive Protein is Associated with Carotid Intimal Medial Thickness in Type 2 Diabetes Mellitus

Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose

Effects of glucose control on the levels of C reactive protein and interleukin-6 in patients with newly onset type 2 diabetics

Contribution of High Sensible Crp (Hscrp) in the Assessment of the Risk of Onset of Type 2 Diabetes and its Cardiovascular Complications

[Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents]

Plasma Hscrp and Glucose Tolerance in Essential Hypertensive Patients

Serum Irisin Level and Its Correlation with Insulin Resistance in Patients with Type 2 Diabetes

Relationship between adipose cytokines and metabolic syndrome in newly diagnosed type 2 diabetes mellitus patients

The relationship of serum inflammatory factors, adiponectin and early atherosclerotic in type 2 diabetes

Serum C-Reactive Protein (crp) and Microalbuminuria in Relation to Fasting and 2-H Postload Plasma Glucose in A Chinese Population